| | US group seeks re-vote on drospirenone clot risk
| | WASHINGTON (Reuters) - A U.S. watchdog group on Thursday urged the Food and Drug Administration to hold a new vote about blood clot risks from popular birth control pills, after advisers to the agency were shown to have ties to the pill makers. | |  |
|
|
| | | | | Clinicians concerned about safety, efficacy of biosimilar drugs
| | | Biosimilars are designed to mimic biologic agents, but they are not precise duplicates of these drugs. Biosimilars may prove useful for treating skin conditions such as psoriasis, but clinicians are waiting for guidance on the drugs from the Food and Drug Administration, which was still pending at press time. |
|
|